t-PA


Also found in: Dictionary, Medical, Encyclopedia.
Related to t-PA: urokinase, heparin
AcronymDefinition
t-PATissue Plasminogen Activator
References in periodicals archive ?
However, very few studies have reported on the rate of t-PA administration and its impact on in-hospital mortality (IHM) in patients hospitalized in Puerto Rico (16).
The plasma TM, t-PA, PAI-1, and VEGF concentrations in the RES and CON groups showed no change at the different time points studied [Table 6],[Table 7],[Table 8],[Table 9].
Although treatment rates are increasing over time (7% in this study) and treatment rates are higher for those eligible for t-PA who arrive within 2 hours (>85%), most patients remain ineligible for thrombolysis because of delayed ED arrival (Bouckaert et al.
2007 (11) FVL mutation H, t-PA Normal development Gursu et al.
PTracer-SV40-truncated mutant t-PA, the product of cloning mutant t-PA gene in pTracer-SV40 was studied in our previous research (18-20).
The associations of plasma levels of some hemostatic variables like fibrinogen, Von Willebrand factor, t-PA and Lp(a) with CHD risk are reported to be attenuated when inflammatory markers and conventional risk factors are included in multivariable analyses.
5) La vida media del t-PA en plasma debido a la inactivacion por alfa 2--antiplasmina es de 90 a 180 minutos, mientras que la inactivacion de t-PA se da en la escala de segundos.
If deemed an appropriate candidate, the local ER physician can administer the t-PA to the patient and then, together with the neurointensivist, they determine whether the patient can be managed locally, or if transfer for more specialized care is needed.
8 Se utilizo transcriptasa reversa (RT) y cambios en la reaccion de polimerasa (PCR) para determinar los cambios de t-PA y del inhibidor del activador del plasminogeno 1 (PAI-1, por sus siglas en ingles) en seis condiciones, a las 6, 12, 24 y 48 horas.
According to a multicenter clinical trial led by Johns Hopkins researchers, the treatment treats a subset of stroke patients by combining minimally invasive surgery, an imaging technique likened to "GPS for the brain", and the clot-busting drug t-PA.
The plaintiff couldn't prove that his condition would have been significantly better even if he'd received t-PA.